JP2006508132A5 - - Google Patents

Download PDF

Info

Publication number
JP2006508132A5
JP2006508132A5 JP2004551898A JP2004551898A JP2006508132A5 JP 2006508132 A5 JP2006508132 A5 JP 2006508132A5 JP 2004551898 A JP2004551898 A JP 2004551898A JP 2004551898 A JP2004551898 A JP 2004551898A JP 2006508132 A5 JP2006508132 A5 JP 2006508132A5
Authority
JP
Japan
Prior art keywords
cannabinoid
alkyl
aryl sulfonate
aryl
substituted benzene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004551898A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006508132A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/035599 external-priority patent/WO2004043946A1/en
Publication of JP2006508132A publication Critical patent/JP2006508132A/ja
Publication of JP2006508132A5 publication Critical patent/JP2006508132A5/ja
Withdrawn legal-status Critical Current

Links

JP2004551898A 2002-11-12 2003-11-06 カンナビノイド結晶性誘導体およびカンナビノイド精製方法 Withdrawn JP2006508132A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42554302P 2002-11-12 2002-11-12
US43502702P 2002-12-20 2002-12-20
PCT/US2003/035599 WO2004043946A1 (en) 2002-11-12 2003-11-06 Cannabinoid crystalline derivatives and process of cannabinoid purification

Publications (2)

Publication Number Publication Date
JP2006508132A JP2006508132A (ja) 2006-03-09
JP2006508132A5 true JP2006508132A5 (enExample) 2007-02-22

Family

ID=32314593

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004551898A Withdrawn JP2006508132A (ja) 2002-11-12 2003-11-06 カンナビノイド結晶性誘導体およびカンナビノイド精製方法

Country Status (13)

Country Link
US (1) US7402686B2 (enExample)
EP (1) EP1560819B1 (enExample)
JP (1) JP2006508132A (enExample)
AT (1) ATE410419T1 (enExample)
AU (1) AU2003287585B2 (enExample)
CA (1) CA2504743C (enExample)
DE (1) DE60324011D1 (enExample)
DK (1) DK1560819T3 (enExample)
ES (1) ES2315548T3 (enExample)
MX (1) MXPA05004966A (enExample)
PT (1) PT1560819E (enExample)
SI (1) SI1560819T1 (enExample)
WO (1) WO2004043946A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1428526A1 (en) * 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
CA2573859A1 (en) 2004-07-19 2006-01-26 Cilag Ltd. Method for obtaining pure tetrahydrocannabinol
CN101132781A (zh) * 2004-12-09 2008-02-27 茵西斯医疗公司 在室温下稳定的屈大麻酚剂型
AU2012201041B2 (en) * 2005-09-29 2012-12-06 Albany Molecular Research, Inc. Process for production of delta-9-tetrahydrocannabinol
CN102766128A (zh) * 2005-09-29 2012-11-07 阿尔巴尼分子研究公司 δ-9-四氢大麻酚的生成方法
US20080112895A1 (en) * 2006-08-04 2008-05-15 Insys Therapeutics Inc. Aqueous dronabinol formulations
GB0702895D0 (en) * 2007-02-14 2007-03-28 Resolution Chemicals Ltd Delta 9 tetrahydrocannabinol derivatives
GB0703284D0 (en) 2007-02-20 2007-03-28 Resolution Chemicals Ltd Delta 9 - tetrahydrocannabinol processing
EP2184983A1 (en) * 2007-08-06 2010-05-19 Insys Therapeutics Inc. Oral cannabinoid liquid formulations and methods of treatment
WO2009099868A1 (en) * 2008-02-06 2009-08-13 Mallinckrodt Inc. Process for the preparation of (-) -delta 9-tetrahydrocannabinol
US10821240B2 (en) 2014-02-11 2020-11-03 Vapor Cartridge Technology Llc Methods and drug delivery devices using cannabis
US9380813B2 (en) 2014-02-11 2016-07-05 Timothy McCullough Drug delivery system and method
US9220294B2 (en) 2014-02-11 2015-12-29 Timothy McCullough Methods and devices using cannabis vapors
US9539295B2 (en) 2014-12-05 2017-01-10 Bradley Michael Bohus Cannabidiol (CBD) enriched alcohol
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US10272360B2 (en) 2017-08-05 2019-04-30 Priya Naturals, Inc. Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
EP3745884A1 (en) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
US10897925B2 (en) 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
CA3119729A1 (en) 2018-10-10 2020-04-16 Treehouse Biotech, Inc. Synthesis of cannabigerol
GB201910389D0 (en) * 2019-07-19 2019-09-04 Gw Pharma Ltd Novel compounds, methods for their manufacture, and uses thereof
US11925907B2 (en) 2019-07-22 2024-03-12 Canopy Growth Corporation Continuous crystallization of cannabinoids in a stirred-tank reactor
EP4030941A1 (en) 2019-09-16 2022-07-27 Vapor Cartridge Technology LLC Drug delivery system with stackable substrates
CN115052868A (zh) * 2020-02-06 2022-09-13 伦敦制药与研究公司 大麻素硫酸酯、及其盐和用途
AU2022362107A1 (en) * 2021-10-11 2024-05-02 Anebulo Pharmaceuticals, Inc. Crystalline forms of a cannabinoid receptor type 1 (cb1) modulator and methods of use and preparation thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507888A (en) 1966-08-30 1970-04-21 Searle & Co Process and intermediates for manufacture of 17-oxygenated estr-4-en-3-ones
US3728360A (en) 1971-08-31 1973-04-17 Little Inc A Ester derivatives of tetrahydrocannabinol
US4188495A (en) 1977-11-14 1980-02-12 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor
US4206225A (en) 1978-09-22 1980-06-03 Pfizer Inc. 2,10-Disubstituted dibenzo[b,d]pyrans and benzo[c]quinolines
US4341906A (en) 1979-09-24 1982-07-27 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes
US4381399A (en) 1981-12-21 1983-04-26 Aerojet-General Corporation Purification of tetrahydrodibenzo[b,d]pyrans from crude synthetic mixtures
GB9303911D0 (en) 1993-02-26 1993-04-14 Zeneca Ltd Chemical process
JP3384163B2 (ja) * 1994-11-09 2003-03-10 株式会社ニコン 顕微鏡対物レンズ
US6008383A (en) 1998-10-26 1999-12-28 University Of Mississippi Method of preparing delta-9-tetrahydrocannabinol esters
JP2008503440A (ja) 2004-06-23 2008-02-07 ビーピー ピー・エル・シー・ 微孔質シリカゲルの合成および合成ガスからのc2酸素化物合成のための触媒の製造に対するその適用

Similar Documents

Publication Publication Date Title
JP2006508132A5 (enExample)
CA2504743A1 (en) Cannabinoid crystalline derivatives and process of cannabinoid purification
JP2005516064A5 (enExample)
TWI689495B (zh) 用於製備3-羥基吡啶甲酸的方法
JP2009515922A (ja) モンテルカストを製造するためのプロセスおよびそのための中間体
JP5485138B2 (ja) エチニルチミジン化合物の精製方法
CN108777958A (zh) 将s-对映体转换成其消旋形式的方法
JP6459703B2 (ja) シクロヘキサンジカルボン酸モノエステル化合物の製造方法
EP1236714A1 (en) Acetalsulfonate derivative, process for producing the same, and process for producing styrene oxide derivative
CN104918924B (zh) 制备氟代内酯衍生物的方法
WO2009016191A1 (en) Process for preparing a leukotriene antagonist and an intermediate thereof
EP3066087B1 (en) A process for the preparation of olopatadine and sylil intermediates thereof
JP4698974B2 (ja) 3−o−アルキルアスコルビン酸の製造法
JP2005053781A (ja) 光学活性な3−(n−メチルアミノ)−1−(2−チエニル)−プロパン−1−オールの製造方法
ZA200402070B (en) Synthesis of 4-(piperidyl)(2-pyridy)methanone-(E)-O-methyloxime and its salts.
JP2002332277A5 (enExample)
EP3596097A1 (en) A process for preparing ketolide compounds
KR100501993B1 (ko) 페닐프로피온산 유도체 또는 그의 염의 제조방법
JP3569877B2 (ja) m−置換−α−ヒドロキシメチルスチレン誘導体の製造法および3−クロロ−α−ブロモスチレン
CN108191728B (zh) 二硫代甲酸衍生物及其制备方法
KR101621754B1 (ko) 잔테이트 화합물을 이용한 α-케토 (시아노메틸렌)트리페닐포스포레인 화합물의 제조방법
CN101356157A (zh) 制备孟鲁司特及其中间体的方法
JPH06122671A (ja) チオエーテル誘導体の製造方法
CN1169989A (zh) 二硫代碳酰亚胺衍生物的制备方法
CN103387540B (zh) 一种成盐法制备唑菌酯的方法